HARP insider transaction filings
Harpoon Therapeutics, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-03-11. Screen HARP transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for HARP between 2026-06-17 and 2026-09-15. The table below lists the most recent filings on record.
Recent Form 4 filings — Harpoon Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-11 | 4 | Chin Mark — Director | Grant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 3,214 (derivative) · Disposition to issuer (D): 2,300 (derivative) | EDGAR |
| 2024-03-11 | 4 | Merck & Co., Inc. — 10% owner MERCK SHARP & DOHME LLC — 10% owner | Purchase (P): 21,397,205 @ $23 | EDGAR |
| 2024-03-11 | 4 | Walker Luke Nathaniel — Chief Medical Officer | Disposition to issuer (D): 135,000 · Disposition to issuer (D): 30,500 (derivative) · Disposition to issuer (D): 10,000 (derivative) | EDGAR |
| 2024-03-11 | 4 | Bucher James B — Chief Legal Officer | Disposition to issuer (D): 110,000 (derivative) | EDGAR |
| 2024-03-11 | 4 | Lanza Frank J — Principal Fin. & Acctng Ofc. | Disposition to issuer (D): 18,734 · Disposition to issuer (D): 8,643 (derivative) · Disposition to issuer (D): 6,499 (derivative) | EDGAR |
| 2024-03-11 | 4 | Robbins Andrew R — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 2,300 (derivative) | EDGAR |
| 2024-03-11 | 4 | DRACHMAN JONATHAN G — Director | Grant/award (A): 415 @ $0 · Disposition to issuer (D): 5,415 · Disposition to issuer (D): 5,531 (derivative) · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 2,300 (derivative) | EDGAR |
| 2024-03-11 | 4 | EASTLAND JULIA MARIE — President and CEO, Director | Grant/award (A): 31,250 @ $0 · Disposition to issuer (D): 269,381 · Disposition to issuer (D): 2,765 (derivative) · Disposition to issuer (D): 40,759 (derivative) | EDGAR |
| 2024-03-11 | 4 | Myers Scott Dunseth — Director | Disposition to issuer (D): 22,665 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 4,600 (derivative) | EDGAR |
| 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. — Director, 10% owner New Leaf Ventures III, L.P. — Director, 10% owner New Leaf Venture Associates III, L.P. — Director, 10% owner New Leaf Venture Management III, L.L.C. — Director, 10% owner New Leaf BPO Associates II, L.P. — Director, 10% owner New Leaf BPO Management II, L.L.C — Director, 10% owner Lathi Vijay K — Director, 10% owner | Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · Disposition to issuer (D): 686,000 (derivative) · Disposition to issuer (D): 85,750 (derivative) | EDGAR |
| 2024-03-11 | 4 | HUNT RONALD — Director, 10% owner | Grant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · +6 more | EDGAR |
| 2024-03-11 | 4 | SILVERNAIL LAUREN P — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 2,300 (derivative) | EDGAR |
| 2024-03-11 | 4 | BAILES JOSEPH S — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 3,142 (derivative) · Disposition to issuer (D): 2,300 (derivative) | EDGAR |
Recent 8-K events — Harpoon Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-11 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HARP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →